Literature DB >> 11948662

Phosphatidylinositol kinase enzymes regulate the retrograde axonal transport of NT-3 and NT-4 in sympathetic and sensory neurons.

Selena E Bartlett1, Anna J Reynolds, Michael Weible, Ian A Hendry.   

Abstract

Phosphatidylinositol 3-kinase (PI3-kinase) and phosphatidylinositol 4-kinase (PI4-kinase) enzymes are an important family of signaling molecules that have been implicated in the regulation of intracellular vesicle trafficking. It has previously been shown that PI3-kinase and PI4-kinase enzymes regulate neuronal survival and the retrograde axonal transport of nerve growth factor in sympathetic and sensory neurons. We have extended these studies to examine the role these enzymes play in the regulation of the retrograde axonal transport of neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4) in sympathetic and sensory neurons in vivo. Wortmannin (0.1 nmol/eye), a PI3-kinase and PI4-kinase antagonist, reduced the amount of (125)I-NT-3 retrograde transport in sympathetic neurons by approximately 50% and (125)I-NT-4 in sympathetic neurons by approximately 40% and sensory neurons by approximately 20%. The PI3-kinase antagonist LY294002 (100 nmol/eye) reduced the retrograde axonal transport of (125)I-NT-4 in sympathetic and sensory neurons, and (125)I-NT-3 in sympathetic neurons. Phenylarsine oxide (PAO), a PI4-kinase antagonist, significantly inhibited (125)I-NT-4 retrograde axonal transport in sympathetic and sensory neurons. These results show that wortmannin-sensitive PI3-kinases and PI4-kinases may be involved in NT-3 and NT-4 retrograde axonal transport. The retrograde axonal transport of neurotrophic factors in sympathetic and sensory neurons in vivo appears to depend upon the activation of different receptors and second messenger cascades at the nerve terminal. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948662     DOI: 10.1002/jnr.10201

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases.

Authors:  Emma L Clayton; Shane Minogue; Mark G Waugh
Journal:  Mol Neurobiol       Date:  2012-10-10       Impact factor: 5.590

2.  Effects of neurotrophins on gastrointestinal myoelectric activities of rats.

Authors:  Ning-Li Chai; Lei Dong; Zong-Fang Li; Ke-Xin Du; Jian-Hua Wang; Li-Kun Yan; Xi-Lin Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons.

Authors:  J Paul Simons; Raya Al-Shawi; Shane Minogue; Mark G Waugh; Claudia Wiedemann; Stylianos Evangelou; Andrzej Loesch; Talvinder S Sihra; Rosalind King; Thomas T Warner; J Justin Hsuan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

4.  Characterization of trkB immunoreactive cells in the intermediolateral cell column of the rat spinal cord.

Authors:  Annemarie M McCartney; Vanessa L Abejuela; Lori G Isaacson
Journal:  Neurosci Lett       Date:  2008-05-21       Impact factor: 3.046

Review 5.  The expanding spectrum of neurological disorders of phosphoinositide metabolism.

Authors:  Jonathan R Volpatti; Almundher Al-Maawali; Lindsay Smith; Aqeela Al-Hashim; Julie A Brill; James J Dowling
Journal:  Dis Model Mech       Date:  2019-08-13       Impact factor: 5.758

6.  Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy.

Authors:  Edgard Verdura; Agustí Rodríguez-Palmero; Valentina Vélez-Santamaria; Laura Planas-Serra; Irene de la Calle; Miquel Raspall-Chaure; Agathe Roubertie; Mehdi Benkirane; Francesco Saettini; Lisa Pavinato; Giorgia Mandrile; Melanie O'Leary; Emily O'Heir; Estibaliz Barredo; Almudena Chacón; Vincent Michaud; Cyril Goizet; Montserrat Ruiz; Agatha Schlüter; Isabelle Rouvet; Julia Sala-Coromina; Chiara Fossati; Maria Iascone; Francesco Canonico; Anna Marcé-Grau; Precilla de Souza; David R Adams; Carlos Casasnovas; Heidi L Rehm; Heather C Mefford; Luis González Gutierrez-Solana; Alfredo Brusco; Michel Koenig; Alfons Macaya; Aurora Pujol
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

7.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.